Al-Shanafey Saud, Habib Zakaria, AlNassar Saleh
Department of Surgery, King Faisal Specialist Hospital and Research Center, Riyadh, Kingdom of Saudi Arabia.
J Pediatr Surg. 2009 Jan;44(1):134-8; discussion 138. doi: 10.1016/j.jpedsurg.2008.10.120.
Persistent hyperinsulinemic hypoglycemia of infancy (PHHI) is considered the most common cause of persistent neonatal hypoglycemia. Management of PHHI involves use of medical agents and its failure is an indication of surgical intervention. Traditionally, an open pancreatectomy was the standard of care but recently laparoscopic pancreatectomy was described. We report our experience with laparoscopic pancreatectomy for PHHI for the period from March 2004 to February 2008.
A retrospective chart review was conducted for patients managed for PHHI with laparoscopic pancreatectomy for that period. Demographic and clinical data were retrieved. Descriptive data were generated, and SPSS version 10 statistical package (SPSS, Chicago, Ill) was used.
Twelve patients diagnosed with PHHI were managed with laparoscopic pancreatectomy for that period. Median age at procedure was 11.5 months (range, 0.5-89 months). Median extent of pancreatectomy was 90% (range, 85%-95%). There were 2 (16%) conversions to open technique. One patient (8%) required reoperation 3 months after the procedure. Patients were followed up for a median of 23.5 months (range, 3-48 months). Four (33%) were euglycemic with no medications. Three patients remained on octreotide postoperatively to be euglycemic, and 3 patients needed a combination of octreotide and diazoxide. One patient remained euglycemic for 10 months then started on octreotide because of recurrence of hypoglycemia. One patient remained hypoglycemic postoperatively and required reoperation 3 months later to control symptoms. He became diabetic 4 months after reoperation on insulin.
Our data suggest that laparoscopic pancreatectomy for medically unresponsive PHHI is feasible and safe. Longer follow-up is needed to ascertain effectiveness.
婴儿持续性高胰岛素血症性低血糖症(PHHI)被认为是持续性新生儿低血糖症最常见的病因。PHHI的治疗包括使用药物,而药物治疗失败则是手术干预的指征。传统上,开放性胰腺切除术是标准治疗方法,但最近有腹腔镜胰腺切除术的报道。我们报告了2004年3月至2008年2月期间我们使用腹腔镜胰腺切除术治疗PHHI的经验。
对该时期接受腹腔镜胰腺切除术治疗PHHI的患者进行回顾性病历审查。收集人口统计学和临床数据。生成描述性数据,并使用SPSS 10.0统计软件包(SPSS,伊利诺伊州芝加哥)。
该时期有12例诊断为PHHI的患者接受了腹腔镜胰腺切除术。手术时的中位年龄为11.5个月(范围为0.5 - 89个月)。胰腺切除的中位范围为90%(范围为85% - 95%)。有2例(16%)转为开放手术。1例患者(8%)在术后3个月需要再次手术。患者的中位随访时间为23.5个月(范围为3 - 48个月)。4例(33%)血糖正常且无需用药。3例患者术后继续使用奥曲肽以维持血糖正常,3例患者需要联合使用奥曲肽和二氮嗪。1例患者血糖正常10个月后因低血糖复发开始使用奥曲肽。1例患者术后仍有低血糖,3个月后需要再次手术以控制症状。再次手术后4个月,他因胰岛素治疗而患糖尿病。
我们的数据表明,对于药物治疗无效的PHHI,腹腔镜胰腺切除术是可行且安全的。需要更长时间的随访以确定其有效性。